210 related articles for article (PubMed ID: 34697773)
1. MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain.
Zhang J; Zhao M; Yan R; Liu J; Maddila S; Junn E; Mouradian MM
Neurotherapeutics; 2021 Oct; 18(4):2529-2540. PubMed ID: 34697773
[TBL] [Abstract][Full Text] [Related]
2. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
[TBL] [Abstract][Full Text] [Related]
3. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
[TBL] [Abstract][Full Text] [Related]
4. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.
Patterson JR; Duffy MF; Kemp CJ; Howe JW; Collier TJ; Stoll AC; Miller KM; Patel P; Levine N; Moore DJ; Luk KC; Fleming SM; Kanaan NM; Paumier KL; El-Agnaf OMA; Sortwell CE
Neurobiol Dis; 2019 Oct; 130():104525. PubMed ID: 31276792
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
Chu Y; Muller S; Tavares A; Barret O; Alagille D; Seibyl J; Tamagnan G; Marek K; Luk KC; Trojanowski JQ; Lee VMY; Kordower JH
Brain; 2019 Nov; 142(11):3565-3579. PubMed ID: 31580415
[TBL] [Abstract][Full Text] [Related]
6. Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
Ferreira N; Gram H; Sorrentino ZA; Gregersen E; Schmidt SI; Reimer L; Betzer C; Perez-Gozalbo C; Beltoja M; Nagaraj M; Wang J; Nowak JS; Dong M; Willén K; Cholak E; Bjerregaard-Andersen K; Mendez N; Rabadia P; Shahnawaz M; Soto C; Otzen DE; Akbey Ü; Meyer M; Giasson BI; Romero-Ramos M; Jensen PH
Acta Neuropathol; 2021 Jul; 142(1):87-115. PubMed ID: 33978813
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice.
Zhang J; Park ES; Park HJ; Yan R; Grudniewska M; Zhang X; Oh S; Yang X; Baum J; Mouradian MM
Neurobiol Aging; 2020 Jan; 85():49-57. PubMed ID: 31734439
[TBL] [Abstract][Full Text] [Related]
8. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex.
Boutros SW; Raber J; Unni VK
J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.
Kim H; Maeng HJ; Kim JH; Yoon JH; Oh Y; Paek SM; Lee Y
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955753
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
[TBL] [Abstract][Full Text] [Related]
11. A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System.
Björklund A; Nilsson F; Mattsson B; Hoban DB; Parmar M
J Parkinsons Dis; 2022; 12(8):2307-2320. PubMed ID: 36189605
[TBL] [Abstract][Full Text] [Related]
12. PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Thomsen MB; Ferreira SA; Schacht AC; Jacobsen J; Simonsen M; Betzer C; Jensen PH; Brooks DJ; Landau AM; Romero-Ramos M
Neurobiol Dis; 2021 Feb; 149():105229. PubMed ID: 33352233
[TBL] [Abstract][Full Text] [Related]
13. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease.
Gou DH; Huang TT; Li W; Gao XD; Haikal C; Wang XH; Song DY; Liang X; Zhu L; Tang Y; Ding C; Li JY
Redox Biol; 2021 Jan; 38():101795. PubMed ID: 33232911
[TBL] [Abstract][Full Text] [Related]
15. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
[TBL] [Abstract][Full Text] [Related]
16. Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease.
Brendza R; Gao X; Stark KL; Lin H; Lee SH; Hu C; Cai H; DiCara D; Hsiao YC; Ngu H; Foreman O; Baca M; Dohse M; Fortin JP; Corpuz R; Seshasayee D; Easton A; Ayalon G; Hötzel I; Chih B
Neurobiol Dis; 2023 Feb; 177():105969. PubMed ID: 36535551
[TBL] [Abstract][Full Text] [Related]
17. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 70 reduces α-synuclein-induced predegenerative neuronal dystrophy in the α-synuclein viral gene transfer rat model of Parkinson's disease.
Moloney TC; Hyland R; O'Toole D; Paucard A; Kirik D; O'Doherty A; Gorman AM; Dowd E
CNS Neurosci Ther; 2014 Jan; 20(1):50-8. PubMed ID: 24279716
[TBL] [Abstract][Full Text] [Related]
19. Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.
Helwig M; Klinkenberg M; Rusconi R; Musgrove RE; Majbour NK; El-Agnaf OM; Ulusoy A; Di Monte DA
Brain; 2016 Mar; 139(Pt 3):856-70. PubMed ID: 26719384
[TBL] [Abstract][Full Text] [Related]
20. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]